Several factors have been associated with persistent HCV viremia after acute HCV infection in the general population and end-stage renal disease patients, including age at infection, symptoms at presentation, mode of infection, rapid HCV viral decline, concomitant HBV infection, and host interleukin-28B genetic variants [15], [16], [28]–[31]. The gene discussed is IFNL3; the disease is chronic kidney disease.